28 June 2023 in Clinical Journal of the American Society of Nephrology
OIon behalf of PRONATREOUS Investigators
on behalf of PRONATREOUS Investigators
+19
International guidelines designed to minimize the risk of complications that can occur when correcting severe hyponatremia have been widely accepted for a decade. On the basis of the results of a recent large retrospective study of patients hospitalized with hyponatremia, it has been suggested that hyponatremia guidelines have gone too far in limiting the rate of rise of the serum sodium concentration; the need for therapeutic caution and frequent monitoring of the serum sodium concentration has been questioned. These assertions are reminiscent of a controversy that began many years ago. After reviewing the history of that controversy, the evidence supporting the guidelines, and the validity of data challenging them, we conclude that current safeguards should not be abandoned. To do so would be akin to discarding your umbrella because you remained dry in a rainstorm. The authors of this review, who represent 20 medical centers in nine countries, have all contributed significantly to the literature on the subject. We urge clinicians to continue to treat severe hyponatremia cautiously and to wait for better evidence before adopting less stringent therapeutic limits.
1 December 2016 in Current Opinion in Nephrology and Hypertension
Primary hypertension is characterized by Na excess and K deficit in the body, which together are key to its pathogenesis. These derangements work jointly in the brain and the peripheral vascular wall to establish hypertension. In this review, we highlight recent evidence describing the central mechanisms through which Na surfeit and K deficit enhance sympathetic nerve activity, thereby raising peripheral vascular resistance and generating hypertension. Animal studies point to a small increase in plasma and cerebrospinal fluid (CSF) [Na], a small decrease in CSF [K], and increased levels of circulating angiotensin II, aldosterone, and endogenous ouabain as the central signals evoking hypertension. These signals are detected by circumventricular organ sensors in the forebrain, and are then relayed to hypothalamic nuclei, which project angiotensinergic effector pathways to brainstem nuclei and spinal preganglionic neurons, triggering increased sympathetic nerve activity and hypertension. These central processes depend on a noncirculating (brain) renin-angiotensin-aldosterone system, local production of endogenous ouabain, and increased oxidative stress. Recent insights into the mechanisms mediating the central effects of Na excess and K deficit on raising sympathetic activity might pave the way for novel approaches to preventing and treating hypertensive disorders.
1 September 2018 in Kidney International Reports
The magnitude of the secondary response to chronic respiratory acidosis, that is, change in plasma bicarbonate concentration ([HCO3-]) per mm Hg change in arterial carbon dioxide tension (PaCO2), remains uncertain. Retrospective observations yielded Δ[HCO3-]/ΔPaCO2 slopes of 0.35 to 0.51 mEq/l per mm Hg, but all studies have methodologic flaws. We studied prospectively 28 stable outpatients with steady-state chronic hypercapnia. Patients did not have other disorders and were not taking medications that could affect acid-base status. We obtained 2 measurements of arterial blood gases and plasma chemistries within a 10-day period. Steady-state PaCO2 ranged from 44.2 to 68.8 mm Hg. For the entire cohort, mean (± SD) steady-state plasma acid-base values were as follows: PaCO2, 52.8 ± 6.0 mm Hg; [HCO3-], 29.9 ± 3.0 mEq/l, and pH, 7.37 ± 0.02. Least-squares regression for steady-state [HCO3-] versus PaCO2 had a slope of 0.476 mEq/l per mm Hg (95% CI = 0.414-0.538, P < 0.01; r = 0.95) and that for steady-state pH versus PaCO2 had a slope of -0.0012 units per mm Hg (95% CI = -0.0021 to -0.0003, P = 0.01; r = -0.47). These data allowed estimation of the 95% prediction intervals for plasma [HCO3-] and pH at different levels of PaCO2 applicable to patients with steady-state chronic hypercapnia. In steady-state chronic hypercapnia up to 70 mm Hg, the Δ[HCO3-]/ΔPaCO2 slope equaled 0.48 mEq/l per mm Hg, sufficient to maintain systemic acidity between the mid-normal range and mild acidemia. The estimated 95% prediction intervals enable differentiation between simple chronic respiratory acidosis and hypercapnia coexisting with additional acid-base disorders.
1 May 2017 in American Journal of Kidney Diseases
We are pleased that Drs Havlin, Matousovic, and Schück1 are in agreement with the conclusions of our recent article.2 However, we would disagree with their assertion that serum sodium-chloride difference is a useful parameter for assessing acid-base status. Quite the contrary, when used as proposed, this parameter can be misleading and therefore can cause errors in diagnosis and management. Whereas the authors would interpret the narrowing of the serum sodium-chloride difference as indicative of normal anion gap (hyperchloremic) metabolic acidosis, it might well evidence respiratory alkalosis or a mixed acid-base disorder. Similarly, widening of the serum sodium-chloride difference is not diagnostic of metabolic alkalosis, but might well be associated with respiratory acidosis or a mixed disorder.